Cinvanti Injection, Emulsion
Product Images NDC 47426-201

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Cinvanti (NDC 47426-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Heron Therapeutics, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image Of The Chemical Structure (Cinvanti 01)

FDA Label Image

Image Of Carton (Principle Panel)

Image Of Carton (Principle Panel)
CINVANTI® (aprepitant) injectable emulsion is a prescription medication for intravenous use only. It is a liquid medication with a concentration of 7.2 mg/mL and must be refrigerated at a temperature of 2°C-8°C (36°F-46°F). CINVANTI® is indicated and used for the prevention of chemotherapy-induced nausea and vomiting. It is supplied in a single-dose vial and should not be frozen.*
FDA Label Image

Image Of Carton (Principle Panel)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.